These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 340036)

  • 1. Phase II study of azotomycin in sarcomas.
    Chang P; Wiernik PH
    Cancer Treat Rep; 1977 Dec; 61(9):1719-20. PubMed ID: 340036
    [No Abstract]   [Full Text] [Related]  

  • 2. Phase II trial of mitoxantrone in advanced sarcomas: a Southwest Oncology Group study.
    Bull FE; Von Hoff DD; Balcerzak SP; Stephens RL; Panettiere FJ
    Cancer Treat Rep; 1985 Feb; 69(2):231-3. PubMed ID: 3882233
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II study of maytansine in advanced sarcomas.
    Edmonson JH; Hahn RG; Creagan ET; O'Connell MJ
    Cancer Treat Rep; 1983 Apr; 67(4):401-2. PubMed ID: 6850657
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II evaluation of pyrazofurin in patients with metastatic sarcoma.
    Gralla RJ; Sordillo PP; Magill GB
    Cancer Treat Rep; 1978 Oct; 62(10):1573-4. PubMed ID: 361228
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial of dianhydrogalactitol in advanced soft tissue and bony sarcomas: a Southwest Oncology Group study.
    Thigpen JT; Samson MK
    Cancer Treat Rep; 1979 Apr; 63(4):553-5. PubMed ID: 445509
    [No Abstract]   [Full Text] [Related]  

  • 6. Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity.
    Catane R; Von Hoff DD; Glaubiger DL; Muggia FM
    Cancer Treat Rep; 1979 Jun; 63(6):1033-8. PubMed ID: 380801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study on DON in patients with previously treated advanced lung cancer.
    Eagan RT; Frytak S; Nichols WC; Creagan ET; Ingle JN
    Cancer Treat Rep; 1982 Aug; 66(8):1665-6. PubMed ID: 6286122
    [No Abstract]   [Full Text] [Related]  

  • 8. Chlorozotocin: phase II evaluation in patients with advanced sarcomas.
    Sordillo PP; Magill GB; Gralla RJ
    Cancer Treat Rep; 1981; 65(5-6):513-4. PubMed ID: 6453647
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II evaluation of vindesine sulfate in patients with advanced sarcomas.
    Sordillo PP; Magill GB; Gralla RJ
    Cancer Treat Rep; 1981; 65(5-6):515-6. PubMed ID: 7237472
    [No Abstract]   [Full Text] [Related]  

  • 10. Cis-dichlorodiammineplatinum(II) in metastatic soft tissue sarcomas.
    Karakousis CP; Holtermann OA; Holyoke ED
    Cancer Treat Rep; 1979; 63(11-12):2071-5. PubMed ID: 393389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Azotomycin (NSC-56654)--clinical brochure.
    Carter SK
    Cancer Chemother Rep 3; 1968 Dec; 1(1):207-17. PubMed ID: 4917775
    [No Abstract]   [Full Text] [Related]  

  • 12. [Role of the antineoplastic antibiotic adriamycin in the chemotherapy of patients with sarcomas].
    Perevodchikova NI; Gorbunova VA
    Vestn Akad Med Nauk SSSR; 1976; (2):67-73. PubMed ID: 1266373
    [No Abstract]   [Full Text] [Related]  

  • 13. [Mitomycin C in the treatment of sarcomas of the soft tissues in the adult in an advanced phase].
    Di Lauro L; Balice A; Papaldo P; Lopez M
    Clin Ter; 1985 Oct; 115(2):83-5. PubMed ID: 3935361
    [No Abstract]   [Full Text] [Related]  

  • 14. Phase II. Evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (AMSA) in patients with advanced sarcoma.
    Sordillo PP; Magill GB; Gralla RJ; Golbey RB
    Cancer Treat Rep; 1980; 64(10-11):1129-30. PubMed ID: 6893950
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experimentation of a new antibiotic-azo dye combination (N4,N4-terephthalal-bis-[D-4-amino-3-isooxazolidone] + 2,6-diamino-3-phenylazo-pyridine hydrochloride) in urinary tract infections].
    Zini S; Marcelli G
    Minerva Urol; 1965; 17(5):206-8. PubMed ID: 5323623
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II evaluation of AMSA in adult sarcomas.
    Yap BS; Plager C; Benjamin RS; Murphy WK; Legha SS; Bodey GP
    Cancer Treat Rep; 1981; 65(3-4):341-3. PubMed ID: 6263473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phase II study of diglycoaldehyde in malignant melanomas and soft tissue sarcomas.
    Vosika GJ; Briscoe K; Carey RW; O'Donnell JF; Perry MC; Budman D; Richards F; Coleman M
    Cancer Treat Rep; 1981; 65(9-10):823-5. PubMed ID: 7273013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of azapicyl in soft tissue sarcomas in children: a report from the Children's Cancer Study Group.
    Heyn R; Krivit W; Sather H; Hammond D
    Cancer Treat Rep; 1982 Feb; 66(2):399-401. PubMed ID: 7034936
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase I clinical study of quelamycin.
    Brugarolas A; Pachon N; Gosalvez M; Llanderal AP; Lacave AJ; Buesa JM; Marco MG
    Cancer Treat Rep; 1978 Oct; 62(10):1527-34. PubMed ID: 361226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II study of mitoxantrone in untreated and previously minimally treated patients with metastatic soft tissue sarcomas.
    Quirt I; Eisenhauer E; Bramwell V; Knowling M; Grafton C; Hirte W; Cripps M; Maksymiuk A
    Cancer Treat Rep; 1987 Nov; 71(11):1109-10. PubMed ID: 3119206
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.